Eyenovia, which is developing delivery devices for the topical treatment of eye diseases, filed on Tuesday with the SEC to raise up to $35 million in an initial public offering.
The New York, NY-based company was founded in 2014 and plans to list on the Nasdaq under the symbol EYEN. Eyenovia filed confidentially on November 15, 2017. Ladenburg Thalmann and Roth Capital are the joint bookrunners on the deal. No pricing terms were disclosed.
